Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies.

MLA

Takheaw, Nuchjira, et al. “Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies.” Biomolecules (2218-273X), vol. 14, no. 11, Nov. 2024, p. 1422. EBSCOhost, https://doi.org/10.3390/biom14111422.

APA

Takheaw, N., Pamonsupornwichit, T., Chaiwut, R., Kotemul, K., Sornsuwan, K., Juntit, O., Yasamut, U., Cheyasawan, P., Laopajon, W., Kasinrerk, W., & Tayapiwatana, C. (2024). Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies. Biomolecules (2218-273X), 14(11), 1422. https://doi.org/10.3390/biom14111422

Chicago

Takheaw, Nuchjira, Thanathat Pamonsupornwichit, Ratthakorn Chaiwut, Kamonporn Kotemul, Kanokporn Sornsuwan, On-anong Juntit, Umpa Yasamut, et al. 2024. “Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies.” Biomolecules (2218-273X) 14 (11): 1422. doi:10.3390/biom14111422.